PROM1 and neoplasm: This suggests the possible active role of the CD133 antigen in the pathophysiological mechanisms of malignancies, and it strongly supports the idea that the levels of CD133 + EVs circulating in the peripheral blood possibly reflect the complex scenario characterizing the cellular frameworks of the tumour.